Variations and Mock-ups

Slides:



Advertisements
Similar presentations
1 Harmonisation of requirements: where we are Erik Waterdrinker, IFAH-Europe 2nd Veterinary Workshop on E-submission 4 Dec 2009, EMEA, London.
Advertisements

BROMI Variations Training Meeting 8 May 2008 BROMI Variations – Training Presentation BROMI Variations Training Meeting, 8 th May 2008, The Cumberland.
Groupings: Several Type IA or IA IN affecting one MA One Type IA or change affecting several MAs from the same MAH Tightening of specification limits (change.
BROMI Variations Training Meeting 8th May 2008 Case Study Session BROMI VARIATIONS.
Product information (II) – aspects relevant for ACTs Regine Lehnert Training workshop: Regulatory requirements for registration of Artemisinin based combined.
The European Agency for the Evaluation of Medicinal Products 1 FFUL LisbonHilde Boone - EMEA 29 May 2003 EU Variation Regulations (541/95 and 542/95) Final.
USPTO Madrid Protocol Seminar on Tips for Filing International Applications and Maintaining International Registrations MPU Review of International Application.
Additives and Contaminants (incl. Flavourings, Extraction Solvents, Enzymes and Ionising Radiation) 30 March 2011.
Federal agency for medicines and health products EXCIPIENTS IN THE LABLE AND PACKAGE LEAFLET OF HOMEOPATHIC MEDICINAL PRODUCTS Patricia Bodart – 23 October.
REGULATION (EC) No 1901/2006 of 12 December 2006 on medicinal products for paediatric use Article 45 and more… Christer Backman CMD(h) Sweden.
Sultan Ghani WHO Prequalification Programme of Priority Essential Medicines, October 2010, Abu Dhabi, U.A.E. Variations Maintenance of Prequalified.
Variations to Prequalified Medicines Rutendo Kuwana Workshop on WHO prequalification requirements for reproductive health medicines, Jakarta, October 2009.
Lynda Paleshnuik | January |1 | Assessment Workshop Copenhagen – January 2011 QIS/QOS: The new PQP quality templates.
Info Day on New Calls and Partner Café Brussels, 8 September 2010 How to apply: Legal Framework - Application Form ( How to ensure that your proposal is.
Update progress EReg Topic Group II on re-registration of vehicles EReg Annual Conference 2011, 12/13 May 2011, Warsaw/Poland Dr. Detlef Marek, KBA/Germany,
The Biocidal Products Directive Presentation to the European Aerosol Federation 28 September 2005 Athens Greece Steve Smith, SC Johnson.
Training Session Product File Notes and Registration Reports, 23 October Registration Report: General aspects M. Trybou Federal Public Service of.
Project implementation, changes, reporting Edmunds Sniķeris Joint Technical Secretariat 16 April 2012, Kuldīga.
OCNLR arrangements for final external moderation and the AVA awards board Summer 2010.
Authorisation of medicinal products: selected challenges Rocío Salvador Roldán Pharmaceuticals Unit/DG SANCO This presentation only reflects the views.
DMF Procedures and Communication between API, FP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
Nursing Library Training using Sunrise Press data.
Meeting for EU Generic Manufacturers and EU MA holders for generic medicines, Copenhagen, 26 November 2009 Generics approved by stringent regulatory authorities:
Acting Director - Policy and Strategy
Paediatric Worksharing CMDh participation Work-sharing in Art 45 and 46 procedures Experiences in Art 29 procedures Presidency meeting 29 September 2011.
2008LIFE presentation LIFE+ call for proposals.
Federal agency for medicines and health products EC REGULATION 1901/2006 ON MEDICINAL PRODUCTS FOR PAEDIATRIC USE AND HOMEOPATHIC MEDICINAL PRODUCTS Marie-Anne.
Ivowen Ltd1 Ivowen Limited Preparation and Submission of a Traditional Herbal Medicinal Product Application.
DMF Procedures and Communication between API, FFP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
Organic Fertilisers and Soil Improvers (OF/SI) Regulation (EC) 1069/ Article 32 Implementing Regulation (EC) 142/2011 –Article 22 and annex XI.
REVISED STATE EMERGENCY RESPONSE PLAN (SERP). Revised State Emergency Response Plan (SERP) SERP overview SERP revision SERP compliance Agency roles Aim.
1 Package on food improvement agents Food additives Food enzymes Flavourings Common procedure Developments since earlier consultation.
PSY 302 Week 1 Assignment Self Confidence Check this A+ tutorial guideline at
PSY 302 Week 2 Assignment Motivational Theories and Factors Check this A+ tutorial guideline at
POST APPROVAL CHANGE MANAGEMENT PROTOCOLS IN THE EUROPEAN UNION
Periodic Safety Update Reports (PSUR)
PLWG Review 6.9 and the Interconnection process
Information on Medicinal Products
Working in Groups in Canvas
Editor’s Guideline Version 1.0
Sossane Nourestani M2 AREIPS Monday 14th November 2016
Annotated, Working Bibliography
Concept of ACSF TAN (Type Approval Number)
Impact Assessment of the revision of Regulation 445/2011
Session II: System authority for ERTMS 4RP Trackside approval
SPCs and the unitary patent package
The role of the HPRA in the authorisation of veterinary medicinal products The role of the Health Products Regulatory Authority in the authorisation of.
Maintaining joint packaging and labelling into the future
Marine Strategy Framework Directive (MSFD)
Cohesion Policy Information and Communication rules The state of play
EU SUBMISSION BY Haripriya & Revathy.
Applications for same biocidal products (NA-BBP)
The report of the State party
Management of product authorizations for in situ cases
Management of product authorization for in situ cases (IGS)
The future of the Pressure Equipment Directive
Implementation of the 9th ATP to anticoagulant rodenticides (estimates based on a publication date by 10/06/2016) New product authorisations.
Changing the Reference Member State (RMS)
Recommendations to facilitate assessment of new application procedures
Exchange of information with the WP.29 secretariat
PROJECT CHANGES.
PROJECT CHANGES.
IFLA LRM adopted! Top congress news!
Prescription-only vs. over-the-counter medicines
Ministerial and Clerical Errors
IPPC Member Consultation 1 July to 1 December 2013
Online Course Change Request Submission
Agent Update - Instructions
Submitting and Accessing 5-year Post-Tenure Review Materials in Vibe
Online Course Change Request Submission
Presentation transcript:

Variations and Mock-ups Top tips: Variations and Mock-ups Grouping Worksharing Grouping is permitted providing the requirements of the Regulation (EC) No 1234/2008 are met. The worksharing procedure is intended to avoid duplication of work. It is possible for competent authorities to process under the same procedure variations to purely national, MR, decentralised and centralised MA’s. A MAH can submit the same type IB or type II variation, or the same group of variations affecting more than one marketing authorisations from the same holder in one application. In case a grouped application is applied within a worksharing application, this may also contain consequential IA changes. MRP/DCP MAs: National MAs: The same rules as for MRP/DCP with the following differences: IA or Type IAIN changes One change to several MAs Several identical changes to several MAs Several changes to one MA A number of changes may be applied for at the same time as a single application. At least one of the changes must be a Type IB, II or an Extension. The changes must also fall within one of the cases listed in Annex III of the Regulation*, or, if they do not fall within one of the cases listed, all member states involved agree to progress the variation as a ‘group’. Grouped applications are only possible within one single member state. To group national MAs from different member states see worksharing procedures One or several changes to several purely national MAs may be submitted as one grouped application, independent from the procedure type. However, the changes have to be identical for all products concerned. These procedures are handled according to the national rules of the relevant competent authority. Harmonisation of the complete initial dossier or SPC and product literature is not a prerequisite. The variation application form must reflect the same ‘present’ and ‘proposed’ situation applicable to all MAs. Type IA/ IAIN variations affecting several MAs is considered as a “group” of variations and not a “worksharing” procedure. Partnership Initiative procedure is no longer available. Extension are excluded from worksharing. Variations How to Group How to do worksharing http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/q_and_a/q_and_a_detail_000100.jsp&mid=WC0b01ac058029bdd6 http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/q_and_a/q_and_a_detail_000101.jsp&mid=WC0b01ac058029bdd7 New and Revised Mock Ups: Top Tips Common Errors: Variations Common Errors:Type IA, Type IAIN, Type IB and Type II variation applications Guideline page not submitted with the application form. Incorrect category chosen for the variation Incorrect procedure type for the variation submitted. Missing documentation pertinent to the application. Insufficient supporting documents. Incorrect or inaccurate information filled in the present and proposed section of the application form. New mock ups: Revised mock ups: Take into consideration the physical size constraints of the container. Clearly indicate if joint labelled with the UK. State the font size for all mock ups. The font size should be in line with the PLS. Full colour mock ups of the smallest and largest pack sizes to be marketed should be submitted as a single pdf file. Include the method of sale and supply and the VPA number. Confirm the date on which the package leaflet was last approved will be updated at print. Confirm the BN and EXP date will be overprinted on the packaging if it is not clear. Do not submit annotated mock ups. Should contain only the text agreed during the procedure and any additional national requirements as outlined in the PLS.   Only the notified change(s) should be incorporated in the mock ups. The inclusion of the distributor on the mock ups is not a national requirement. If the applicant includes the distributor a national variation application (C.II.6.a – Type 1Ain) is required. When joint labelled with the UK and changes are proposed to the UK only box, IE do not require a variation. For joint-labelling procedures, refer to the clarification paper on joint labelling between Ireland and the UK for variation categories. Where there are significant changes to the mock ups (e.g. layout and / or design), the font size should be stated and in line with the PLS. The final version of mock ups should not be annotated. There is no requirement to submit all mock ups unless impacted by the change.